Arinna Lifesciences Limited, a active public limited company, was established on 29 August 2013 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230GJ2013PLC076619. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹13.06 Cr.
Formerly known as Arinna Lifesciences Limited, Arinna Lifesciences Private Limited. It upholds a compliant status. Employing 321 professional, Its leadership includes Siddharth Shah (Director), Shankar Gopalakrishnan (Director), Rohit Brijmohan Mantri (Nominee Director). Past directors included Siddharth Shah, Shankar Gopalakrishnan, Trushit Indravadan Chokshi. It holds ₹9.00 M open charges and ₹6.15 Cr settled loans. Its latest AGM occurred on 15 September 2025, with the balance sheet filed on 31 March 2025. It is based at A- 301 To 307, 3Rd Floor, Sankalp Iconic Tower, Iskcon-Ambli Road, Off. S G Highway, Ahmedabad, Gujarat, 380054.
U24230GJ2013PLC076619
076619
29 August 2013
₹15.00 Cr
₹13.06 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Arinna Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth Shah | Director | 23 Apr 2015 | Current |
| Shankar Gopalakrishnan | Director | 23 Apr 2015 | Current |
| Rohit Brijmohan Mantri | Nominee Director | 03 May 2016 | Current |
| Vivek Seth | Managing Director | 29 Aug 2013 | Current |
| Shilpa Vivek Seth | Director | 29 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Sep 2016 | Past |
| Pramod Abcsdd | Director | 05 Jan 2015 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arinna Lifesciences Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.75% increase. The company also saw a substantial fall in profitability, with a 19.93% decrease in profit. The company's net worth Soared by an impressive increase of 11.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Arinna Lifesciences had a promoter holding of 38.16% and a public holding of 61.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,000,000.00
₹61,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2025 | Others | ₹9.00 M | Open |
| 01 Apr 2021 | Axis Bank Limited | ₹3.00 Cr | Satisfied |
| 26 Feb 2018 | Axis Bank Limited | ₹3.15 Cr | Satisfied |
Explore comprehensive loan charge details -
Arinna Lifesciences has a workforce of 321 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Arinna Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arinna Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Arinna Lifesciences Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records. was documented.
Progress on Astha Premswaroop Kumavat was appointed as a Company Secretary was appointed as a Company Secretary on 28 Jul 2025 & has been associated with this company since 4 months 5 days . was documented.
Arinna Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
The activity A charge registered on 01 Apr 2021 via Charge ID 100439973 with Axis Bank Limited was fully satisfied on 10 Jan 2025. was completed.
Progress on A charge with Others amounted to Rs. 0.90 Cr with Charge ID 101032839 was registered on 06 Jan 2025. was documented.
Subramaniam Iyer was appointed as a CFO was appointed as a CFO on 17 May 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
Arinna operates with 18 regional offices, more than 680 stockists and its products are sold in over 23 states across the county, the company website claims. .
The CIN of Arinna Lifesciences Limited is U24230GJ2013PLC076619.
Arinna Lifesciences Limited is headquartered at A- 301 To 307, 3Rd Floor, Sankalp Iconic Tower, Iskcon-Ambli Road, Off. S G Highway, Ahmedabad, Gujarat, 380054.
Arinna Lifesciences Limited was incorporated on 29 August 2013.
The current directors of Arinna Lifesciences Limited are
The primary industry of Arinna Lifesciences Limited is Trade.
Arinna Lifesciences Limited is unlisted.
The authorized capital of Arinna Lifesciences Limited is ₹15.00 Cr, and the paid-up capital is ₹13.06 Cr.
The compliance status of Arinna Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX